Pharma major Dr Reddy’s Laboratories has launched over-the-counter Lansoprazole delayed-release capsules in the US market.
The Hyderabad-based company will market the product under store brand labels in the US market.
The product is the bioequivalent version of Novartis Consumer Health’s Prevacid 24 HR capsule. It had brand sales of approximately $115 million in the 12 months ending March 31, 2012, according to market estimates.
The tablets are generally indicated for treating rheumatoid arthritis and osteoarthritis.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.